期刊
INTERNATIONAL JOURNAL OF CANCER
卷 148, 期 11, 页码 2815-2824出版社
WILEY
DOI: 10.1002/ijc.33458
关键词
hepatic tumorigenesis; synNotch; transgenesis; Wnt; xenograft; zebrafish models
类别
The study demonstrates a novel approach to therapeutically target specific focuses by inhibiting aberrant Wnt activity without interfering with normal tissues using synthetic cell-based therapy. Successful proof of principle in an in vivo model suggests the potential of combining synthetic cells with antigen receptors to enhance treatment accuracy.
The canonical Wnt signaling pathway is activated in numerous contexts, including normal and cancerous tissues. Here, we describe a synthetic cell-based therapeutic strategy that inhibits aberrant Wnt activity in specific focuses without interfering with the normal tissues in vivo. As a proof of principle, we generated a triple transgenic zebrafish liver cancer model that conditionally expressed human MET and induced ectopic Wnt signaling in hepatocytes. Then, we generated a customized synthetic Notch receptor (synNotch) cascade to express Wnt inhibitor DKK1 in Jurkat T cells and human peripheral blood mononuclear cells (PBMCs) after recognizing MET as antigen. After that, the synNotch PBMCs were sorted and microinjected into different tissues of the zebrafish model. In MET-expressing cancerous liver tissues, the injected cells expressed DKK1 and inhibited the local proliferation and Wnt activity; while in the yolk sac without MET, the injected cells remained inactive. Overall, our studies revealed the use of synthetic cells with antigen receptors to improve the spatiotemporal accuracy of anti-Wnt therapy, and proposed that the genetically humanized zebrafish model may serve as a small-scale and highly optically accessible platform for the functional evaluation of human synthetic cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据